Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jun;36(6):360-73.
doi: 10.1016/j.tips.2015.04.006. Epub 2015 May 9.

New therapeutic targets for cancer bone metastasis

Affiliations
Review

New therapeutic targets for cancer bone metastasis

Jing Y Krzeszinski et al. Trends Pharmacol Sci. 2015 Jun.

Abstract

Bone metastases are dejected consequences of many types of tumors including breast, prostate, lung, kidney, and thyroid cancers. This complicated process begins with the successful tumor cell epithelial-mesenchymal transition, escape from the original site, and penetration into the circulation. The homing of tumor cells to the bone depends on both tumor-intrinsic traits and various molecules supplied by the bone metastatic niche. The colonization and growth of cancer cells in the osseous environment, which awaken their dormancy to form micro- and macro-metastasis, involve an intricate interaction between the circulating tumor cells and local bone cells including osteoclasts, osteoblasts, adipocytes, and macrophages. We discuss the most recent advances in the identification of new molecules and novel mechanisms during each step of bone metastasis that may serve as promising therapeutic targets.

Keywords: bone metastatic niche; bone microenvironment; macrometastasis; osteoblast; osteoclast; tumor-intrinsic factors.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Multiple steps in cancer bone metastasis and the major regulatory factors in the tumor-bone microenvironment
The cellular basis of cancer progression includes tumor cell local invasion, intravasation, survival in the circulation, extravasation, colonization and thriving in the bone. In the primary site, tumor cells undergo EMT, ECM degradation and angiogenesis to invade vascular or lymphatic circulation (A). After intravasation, a few tumor cells can survive from NK cells attack with the assistance of platelets (B). Through the communication between tumor intrinsic factors and factors in the osseous environment, cancer cells extravasate to the bone and marrow. Interactions between tumor cells and bone cells mediated by adhesion molecules are critical for colonization (C). After landing, tumor cells start to interact with local cells, including osteoclasts, osteoblasts, adipocytes and macrophages, in order to thrive in bone and form micro- and macro-metastasis (D).
Figure 2
Figure 2. Illustration of osteolytic and osteoblastic bone metastatic lesions
Cancer causes predominantly two types of bone metastatic lesions based on the radiological appearance, with bone destructions observed in osteolytic bone metastatic lesions (A), while bone forming phenotypes are observed in osteoblastic bone metastatic lesions (B).

Similar articles

Cited by

References

    1. Randall RL. A promise to our patients with metastatic bone disease. Ann Surg Oncol. 2014;21:4049–4050. - PubMed
    1. Davila D, et al. Evaluation of Osseous Metastasis in Bone Scintigraphy. Seminars in Nuclear Medicine. 2015;45:3–15. - PubMed
    1. Quinn RH, et al. Contemporary management of metastatic bone disease: tips and tools of the trade for general practitioners. Instr Course Lect. 2014;63:431–441. - PubMed
    1. Taubenberger AV. In vitro microenvironments to study breast cancer bone colonisation. Adv. Drug Deliv. Rev. 2014;79-80C:135–144. - PubMed
    1. Jandial R. Metastatic Cancer. Clinical and Biological Perspective. 2013:1–314.

Publication types

MeSH terms

Substances